Scinai Immunotherapeutics Ltd

SCNI

Company Profile

  • Business description

    Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

  • Contact

    Hadassah Ein Kerem Campus
    2nd Floor, Jerusalem BioPark
    Jerusalem
    ISR

    T: +972 89302529

    https://www.scinai.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    31

Stocks News & Analysis

stocks

Investors overly negative on cheap ASX share

We cut our fair value by 26% but the market has overreacted.
stocks

Overvalued US AI play reports earnings

Strong earnings with high projected growth but price is too rich.
stocks

Continuing problems at the ASX

Interim report by financial regulator is a hit to sentiment.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,918.304.700.05%
CAC 408,152.091.450.02%
DAX 4024,212.3812.880.05%
Dow JONES (US)47,951.8565.880.14%
FTSE 1009,845.818.040.08%
HKSE25,690.53192.400.75%
NASDAQ23,006.36313.041.38%
Nikkei 22549,507.21505.711.03%
NZX 50 Index13,333.4076.630.58%
S&P 5006,774.7653.330.79%
S&P/ASX 2008,621.400.10-0.00%
SSE Composite Index3,890.4514.080.36%

Market Movers